ANIKA THERAPEUTICS INC (ANIK) Stock News

NASDAQ:ANIK - Nasdaq - US0352551081 - Common Stock - Currency: USD

10.5 -0.74 (-6.58%)

After market: 10.5 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ANIK Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Anika Therapeutics Inc.

Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025

3 days ago - By: Anika Therapeutics Inc.

Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025

16 days ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Zacks Investment Research - Mentions: GOGO PAA ENB

Company News for May 12, 2025

2 months ago - By: Benzinga

A Glimpse of Anika Therapeutics's Earnings Potential

16 days ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Zacks Investment Research - Mentions: YMAB

Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates

2 months ago - By: Anika Therapeutics Inc.

Anika Reports First Quarter 2025 Financial Results

2 months ago - By: Benzinga - Mentions: PAR TLS BKV STWD ...

Earnings Scheduled For May 9, 2025

2 months ago - By: Zacks Investment Research - Mentions: VCEL

Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates

2 months ago - By: Anika Therapeutics Inc.

Anika to Participate in the Sidoti Virtual Investor Conference

2 months ago - By: Anika Therapeutics Inc.

Anika to Participate in the Sidoti Virtual Investor Conference

3 months ago - By: Anika Therapeutics Inc.

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

3 months ago - By: Anika Therapeutics Inc.

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

3 months ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Anika Therapeutics Inc.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Anika Therapeutics Inc.

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

4 months ago - By: Anika Therapeutics Inc.

Anika Completes Divestiture of Parcus Medical

4 months ago - By: Anika Therapeutics Inc.

Anika Completes Divestiture of Parcus Medical

5 months ago - By: Anika Therapeutics Inc.

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

5 months ago - By: Anika Therapeutics Inc.

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

5 months ago - By: Anika Therapeutics Inc.

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

5 months ago - By: Anika Therapeutics Inc.

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

7 months ago - By: Anika Therapeutics Inc.

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

7 months ago - By: Anika Therapeutics Inc.

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

8 months ago - By: Anika Therapeutics Inc.

Anika To Participate in December 2024 Investor Conferences

8 months ago - By: Anika Therapeutics Inc.

Anika To Participate in December 2024 Investor Conferences